PRVA · NASDAQ
Privia Health Group (PRVA) Stock Price & Fundamentals
Privia Health Group (PRVA) closed at $475.96 on Oct 9, 2026, up 1.83% from the previous close of $467.40.
Share price, past year
1Y +22.55%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $475.96 |
| Sep 30, 2026 | $471.25 |
| Aug 31, 2026 | $467.96 |
| Jul 31, 2026 | $444.78 |
| Jun 30, 2026 | $430.69 |
| May 29, 2026 | $426.95 |
| Apr 30, 2026 | $414.43 |
| Mar 31, 2026 | $427.03 |
| Feb 27, 2026 | $429.98 |
| Jan 30, 2026 | $427.80 |
| Dec 31, 2025 | $412.23 |
| Nov 28, 2025 | $400.25 |
| Oct 31, 2025 | $399.92 |
Key statistics
- Market cap
- $60.11B
- P/E (TTM)
- 2,163.5
- EPS (TTM)
- $0.22
- Revenue (TTM)
- $2.36B
- Net income (TTM)
- $28.12M
- Shares outstanding
- 126.3M
- Dividend yield
- —
- 52-week range
- $388.37 – $480.97
Privia Health Group's market cap is $60.11B, based on a share price of $475.96 and 126.3M shares outstanding as of Jun 30, 2026.
Financials
Privia Health Group reported revenue of $2.12B for fiscal 2025, up 22.26% from fiscal 2024.
Privia Health Group earned net income of $22.92M in fiscal 2025, a net margin of 1.1%.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.12B | +22.3% | $22.92M | 1.1% | $0.18 | — |
| FY2024ended Dec 31, 2024 | $1.74B | +4.7% | $14.39M | 0.8% | $0.11 | — |
| FY2023ended Dec 31, 2023 | $1.66B | +22.2% | $23.08M | 1.4% | $0.19 | $80.67M |
| FY2022ended Dec 31, 2022 | $1.36B | +40.4% | −$8.59M | −0.6% | −$0.08 | $47.09M |
| FY2021ended Dec 31, 2021 | $966.22M | +18.3% | −$188.23M | −19.5% | −$1.83 | $54.51M |
| FY2020ended Dec 31, 2020 | $817.08M | +3.9% | $31.24M | 3.8% | $0.33 | $38.51M |
| FY2019ended Dec 31, 2019 | $786.36M | — | $8.24M | 1.1% | $0.09 | $18.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $632.63M | $9.05M | $0.07 |
| Q1 FY2026ended Mar 31, 2026 | $603.85M | $3.06M | $0.02 |
| Q4 FY2025ended Dec 31, 2025 | $541.17M | $9.15M | $0.08 |
| Q3 FY2025ended Sep 30, 2025 | $580.42M | $6.86M | $0.05 |
| Q2 FY2025ended Jun 30, 2025 | $521.15M | $2.69M | $0.02 |
| Q1 FY2025ended Mar 31, 2025 | $480.10M | $4.22M | $0.03 |
| Q4 FY2024ended Dec 31, 2024 | $460.90M | $4.40M | $0.03 |
| Q3 FY2024ended Sep 30, 2024 | $437.92M | $3.54M | $0.03 |
Company profile
- Name
- Privia Health Group, Inc.
- Ticker
- PRVA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Health Services
- Headquarters
- 950 N. Glebe Rd., Suite 700, Arlington, VA 22203
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001759655
Recent SEC filings
- Aug 18, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 7, 2026
- May 22, 2026
- May 7, 2026
- May 7, 2026
- Feb 27, 2026
Frequently asked questions
What is Privia Health Group's stock price?
Privia Health Group (PRVA) closed at $475.96 on Oct 9, 2026, up 1.83% from the previous close of $467.40.
What is Privia Health Group's market cap?
Privia Health Group's market cap is $60.11B, based on a share price of $475.96 and 126.3M shares outstanding as of Jun 30, 2026.
How much revenue does Privia Health Group make?
Privia Health Group reported revenue of $2.12B for fiscal 2025, up 22.26% from fiscal 2024.
What is PRVA's P/E ratio?
Privia Health Group's price-to-earnings ratio is 2,163.5, based on trailing twelve-month diluted EPS of $0.22.
Does Privia Health Group pay a dividend?
Privia Health Group's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Privia Health Group, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures